Respiratory-Related Hospitalizations following Prophylaxis in the Canadian Registry for Palivizumab (2005–2012) Compared to Other International Registries

Respiratory syncytial virus (RSV) infection occurs commonly in infants aged ≤2 years, and severe infection results in hospitalization with accompanying morbidity and mortality. Palivizumab has been available for prophylaxis for the past 15 years. Prospective data on patients who received palivizumab...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Paes, Bosco, Mitchell, Ian, Li, Abby, Harimoto, Tetsuhiro, Lanctôt, Krista L.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Hindawi Publishing Corporation 2013
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3703731/
https://ncbi.nlm.nih.gov/pubmed/23861694
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/917068
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia